| US 7,537,900 B2 | ||
| Method for diagnosing multiple sclerosis | ||
| Nir Dotan, Rehovot (Israel); Avinoam Dukler, Modeiin (Israel); Mikael Schwarz, Kiryat Uno (Israel); and Ari Gargir, Givatayim (Israel) | ||
| Assigned to Glycominds Ltd., Lod (Israel) | ||
| Filed on Aug. 04, 2003, as Appl. No. 10/634,309. | ||
| Claims priority of provisional application 60/400914, filed on Aug. 02, 2002. | ||
| Claims priority of provisional application 60/447076, filed on Feb. 13, 2003. | ||
| Claims priority of provisional application 60/462984, filed on Apr. 15, 2003. | ||
| Claims priority of provisional application 60/473231, filed on May 23, 2003. | ||
| Prior Publication US 2004/0077023 A1, Apr. 22, 2004 | ||
| This patent is subject to a terminal disclaimer. | ||
| Int. Cl. G01N 33/53 (2006.01) | ||
| U.S. Cl. 435—7.1 [436/811] | 7 Claims |
| 1. A method of diagnosing multiple sclerosis in a subject, the method comprising
providing a blood sample from a subject; detecting in said blood sample an anti-Glc (α1-4) Glc (α)IgM type antibody; and
comparing the levels of said antibody in said blood sample to the levels of said antibody in a normal control sample, wherein
a higher level of said antibody in said blood sample compared to the level of said antibody in a normal control sample is
indicative of multiple sclerosis,
thereby diagnosing multiple sclerosis in said subject, wherein said diagnosis is after a first neurological attack and prior
to a second neurological attack.
|